Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela B Smith

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Cancer|May 26, 2016
Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancerTracy L Rose, Allison M Deal, Matthew E Nielsen, et al.
Urologic Oncology|March 14, 2016
Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011Anne G Ording, Matthew E Nielsen, Angela B Smith, et al.
JMIR Infodemiology|February 12, 2025
Identifying Misinformation About Unproven Cancer Treatments on Social Media Using User-Friendly Linguistic Characteristics: Content AnalysisIlona Fridman, Dahlia Boyles, Ria Chheda, et al.
The Journal of Urology|November 7, 2025
Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 Trial: ErratumAngela M Stover, Dana Mueller, Jessica Carda-Auten, et al.
The Journal of Urology|March 6, 2025
Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 TrialAngela M Stover, Dana Mueller, Jessica Carda-Auten, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinomaAhmad Shabsigh, Nir Kleinmann, Angela B Smith, et al.
The Journal of Surgical Research|August 6, 2014
Geriatric assessment in surgical oncology: a systematic reviewMegan A Feng, Daniel T McMillan, Karen Crowell, et al.
Urologic Oncology|November 4, 2015
Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigenAaron D Falchook, Neil E Martin, Ramsankar Basak, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder CancerAvani Desai, Lucas Bouknight, Thomas Reed, et al.
Urology|January 28, 2015
Readability of American online patient education materials in urologic oncology: a need for simple communicationAmanda Pruthi, Matthew E Nielsen, Mathew C Raynor, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Cancer|May 26, 2016
Sex disparities in use of chemotherapy and survival in patients with advanced bladder cancerTracy L Rose, Allison M Deal, Matthew E Nielsen, et al.
Urologic Oncology|March 14, 2016
Venous thromboembolism and effect of comorbidity in bladder cancer: A danish nationwide cohort study of 13,809 patients diagnosed between 1995 and 2011Anne G Ording, Matthew E Nielsen, Angela B Smith, et al.
JMIR Infodemiology|February 12, 2025
Identifying Misinformation About Unproven Cancer Treatments on Social Media Using User-Friendly Linguistic Characteristics: Content AnalysisIlona Fridman, Dahlia Boyles, Ria Chheda, et al.
The Journal of Urology|November 7, 2025
Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 Trial: ErratumAngela M Stover, Dana Mueller, Jessica Carda-Auten, et al.
The Journal of Urology|March 6, 2025
Perceived Impact on Patient Routines/Responsibilities for Surgery and a Nonsurgical Primary Treatment Option in Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer: Findings From the ENVISION Phase 3 TrialAngela M Stover, Dana Mueller, Jessica Carda-Auten, et al.
Cancer Chemotherapy and Pharmacology|March 7, 2021
Pharmacokinetics of UGN-101, a mitomycin-containing reverse thermal gel instilled via retrograde catheter for the treatment of low-grade upper tract urothelial carcinomaAhmad Shabsigh, Nir Kleinmann, Angela B Smith, et al.
The Journal of Surgical Research|August 6, 2014
Geriatric assessment in surgical oncology: a systematic reviewMegan A Feng, Daniel T McMillan, Karen Crowell, et al.
Urologic Oncology|November 4, 2015
Stage at presentation and survival outcomes of patients with Gleason 8-10 prostate cancer and low prostate-specific antigenAaron D Falchook, Neil E Martin, Ramsankar Basak, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder CancerAvani Desai, Lucas Bouknight, Thomas Reed, et al.
Urology|January 28, 2015
Readability of American online patient education materials in urologic oncology: a need for simple communicationAmanda Pruthi, Matthew E Nielsen, Mathew C Raynor, et al.
Pageof 17